More than Just Paper Shuffling and Regulations
, Country Head Pharmacovigilance Germany at Bayer Pharmaceuticals, joined the to explain how pharmacovigilance can be a rich and rewarding field. The lively discussion covered a far-reaching variety of topics, including:
- The importance of having practitioners with diverse backgrounds
- The need for predictive analytics
- Ways to improve patient centricity
Dr. Nanciu, who also lectures on pharmacovigilance at universities throughout Germany, tells her students that “pharmacovigilance is like medicine on paper. So you have your patients, you have their adverse event reports, you have their entire history, diagnostic, lab values, disease, evolution, and you can see their evolution through a disease.”
To hear more from Safety Signals, check us out on Apple Podcasts, Spotify, or on our website.
Listening on a desktop and can’t see the links? Just search for Safety Signals on your favorite podcast player.
The views of the hosts and guests featured on Safety Signals are their own and do not necessarily reflect the views of Saama or the individual companies for which the guests may work.